Search for: "Impax Laboratories, LLC"
Results 1 - 18
of 18
Sorted by Relevance
|
Sort by Date
12 Dec 2010, 9:47 pm
Hunt • Defendants: IMPAX Laboratories, Inc.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc. [read post]
3 Feb 2013, 8:26 pm
Laboratories, Inc.; Purdue Pharmaceuticals L.P.; Rhodes Technologies • Defendant: Impax Laboratories, Inc.... [read post]
30 Apr 2018, 10:30 am
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
30 Apr 2018, 10:30 am
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
25 Jun 2012, 1:27 pm
Relying on Impax Laboratories v. [read post]
17 Feb 2010, 8:00 am
Impax Laboratories Inc. [read post]
9 Oct 2009, 9:11 am
Impax Laboratories (patent infringement) 9/18: Ricoh Company Ltd. and Ricoh Americas Corporation v. [read post]
27 Oct 2021, 5:15 am
(functional trade dress); Impax Laboratories, Inc. v. [read post]
26 Feb 2014, 5:37 pm
Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
1 Dec 2010, 12:15 am
Navinta LLC (Property, intangible) Pulmicort Respules (Budesonide) – US: Liability for future indirect infringement: AstraZeneca LP v. [read post]
10 Jun 2010, 3:58 am
LLC et al. v. [read post]
5 May 2010, 4:46 am
Impax Laboratories Inc. [read post]
16 Jun 2010, 3:02 pm
Paddock Laboratories Inc. [read post]
25 Aug 2010, 12:37 am
(Patent Docs) Clobex (Clobetasol propionate) – US: Patent infringement complaint filed following a Paragraph IV certification: Galderma Laboratories, L.P. et al. v. [read post]
10 Feb 2010, 4:47 pm
Impax Laboratories Inc. [read post]
20 Nov 2007, 12:12 pm
Impax Laboratories, Inc., 2006 WL 3091331, *2 (D. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) – Lundbeck wins… [read post]
29 Aug 2008, 1:25 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
